YK-2168 is an CDK9 inhibitor. YK2168 exhibited improved CDK9 selectivity over AZD4573 and BAY1251152; also showed differentiated intravenous PK profile and remarkable solid tumor efficacy in a mouse gastric cancer SNU16 CDX model in preclinical studies.
MedKoo Cat#: 128104
Name: YK-2168
CAS#: 2571068-74-9
Chemical Formula: C16H18ClN5
Exact Mass: 315.1251
Molecular Weight: 315.81
Elemental Analysis: C, 60.85; H, 5.75; Cl, 11.23; N, 22.18
The following data is based on the product molecular weight 315.81 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |